Literature DB >> 28043733

Potential problems surrounding the use of sublingually administered ophthalmic atropine for sialorrhea.

Jonathan G Leung1, Kathryn M Schak2.   

Abstract

Entities:  

Keywords:  Atropine; Clozapine; Ophthalmic; Sialorrhea

Mesh：

Substances：

Year:  2016        PMID： 28043733     DOI： 10.1016/j.schres.2016.12.028

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  2 in total

Review 1.  Hypersalivation: update of the German S2k guideline (AWMF) in short form.

Authors:  Armin Steffen; Wolfgang Jost; Tobias Bäumer; Dirk Beutner; Sabine Degenkolb-Weyers; Martin Groß; Maria Grosheva; Samer Hakim; Kai G Kahl; Rainer Laskawi; Rebekka Lencer; Jan Löhler; Thekla Meyners; Saskia Rohrbach-Volland; Rainer Schönweiler; Sara-Christina Schröder; Sebastian Schröder; Heidrun Schröter-Morasch; Maria Schuster; Susanne Steinlechner; Roland Urban; Orlando Guntinas-Lichius
Journal:  J Neural Transm (Vienna)       Date:  2019-04-10       Impact factor: 3.575

2.  The sublingual use of atropine in the treatment of clozapine-induced sialorrhea: A systematic review.

Authors:  Thomas Van der Poorten; Marc De Hert
Journal:  Clin Case Rep       Date:  2019-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.